Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lobb

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|March 29, 2012
Science in liquid dietary supplement promotion: the misleading case of mangosteen juiceAno L Lobb
The International Journal of Neuroscience|August 1, 1986
Pattern of eyelid motion predictive of decision errors during drowsiness: oculomotor indices of altered statesM L Lobb, J A Stern
The Psychiatric Quarterly|July 1, 2010
Recovery-oriented training and staff attitudes over time in two state hospitalsJack Tsai, Michelle P Salyers, Angela L Lobb
Perceptual and Motor Skills|October 1, 1984
A behavioral technique for recovery from the psychological trauma of hysterectomyM L Lobb, M C Shannon, S L Recer, et al.
Developmental Medicine and Child Neurology|January 29, 2003
Reliability and validity of the Observational Gait Scale in children with spastic diplegiaAnna H Mackey, Glenis L Lobb, Sharon E Walt, et al.
Protein Engineering|December 1, 1996
Expression, purification and characterization of recombinant crambinL Lobb, B Stec, E K Kantrowitz, et al.
Life Sciences|January 1, 1997
The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigsL A Phebus, K W Johnson, P W Stengel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2026
Curated set of tool compounds to probe PYK2 and FAK signaling in Alzheimer's diseasePathum M Weerawarna, Cynthia D Jesudason, Karen L Lobb, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Expedited discovery of second generation NK-1 antagonists: identification of a nonbasic aryloxy substituentJ E Fritz, P A Hipskind, K L Lobb, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonistB D Gitter, R F Bruns, J J Howbert, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|March 29, 2012
Science in liquid dietary supplement promotion: the misleading case of mangosteen juiceAno L Lobb
The International Journal of Neuroscience|August 1, 1986
Pattern of eyelid motion predictive of decision errors during drowsiness: oculomotor indices of altered statesM L Lobb, J A Stern
The Psychiatric Quarterly|July 1, 2010
Recovery-oriented training and staff attitudes over time in two state hospitalsJack Tsai, Michelle P Salyers, Angela L Lobb
Perceptual and Motor Skills|October 1, 1984
A behavioral technique for recovery from the psychological trauma of hysterectomyM L Lobb, M C Shannon, S L Recer, et al.
Developmental Medicine and Child Neurology|January 29, 2003
Reliability and validity of the Observational Gait Scale in children with spastic diplegiaAnna H Mackey, Glenis L Lobb, Sharon E Walt, et al.
Protein Engineering|December 1, 1996
Expression, purification and characterization of recombinant crambinL Lobb, B Stec, E K Kantrowitz, et al.
Life Sciences|January 1, 1997
The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigsL A Phebus, K W Johnson, P W Stengel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2026
Curated set of tool compounds to probe PYK2 and FAK signaling in Alzheimer's diseasePathum M Weerawarna, Cynthia D Jesudason, Karen L Lobb, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Expedited discovery of second generation NK-1 antagonists: identification of a nonbasic aryloxy substituentJ E Fritz, P A Hipskind, K L Lobb, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonistB D Gitter, R F Bruns, J J Howbert, et al.
Pageof 2